U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180481180481Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung CancerCompletedHas ResultsNon Small Cell Lung CancerDrug: gemcitabine|Drug: cisplatin|Radiation: radiationhttps://ClinicalTrials.gov/show/NCT00192036
180482180482An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).CompletedHas ResultsAttention Deficit Hyperactivity Disorder|Oppositional Defiant DisorderDrug: atomoxetine 0.5 mg/kg/day|Drug: placebo|Drug: atomoxetine 1.2 mg/kg/day|Drug: atomoxetine 1.2-1.4 mg/kg/dayhttps://ClinicalTrials.gov/show/NCT00192023
180483180483Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNo Results AvailableBipolar DisorderDrug: Olanzapinehttps://ClinicalTrials.gov/show/NCT00191997
180484180484A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal CancerCompletedHas ResultsMetastatic Colorectal CancerDrug: pemetrexed|Drug: irinotecanhttps://ClinicalTrials.gov/show/NCT00191984
1804851804852nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenCompletedNo Results AvailableUrologic Neoplasms|Carcinoma, Transitional CellDrug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00191971
180486180486Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedHas ResultsAttention Deficit Hyperactivity DisorderDrug: Atomoxetine Hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT00191945
180487180487Switching to Duloxetine From Other AntidepressantsCompletedNo Results AvailableMajor Depressive DisorderDrug: Duloxetinehttps://ClinicalTrials.gov/show/NCT00191932
180488180488A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNo Results AvailableDepressive Disorder, MajorDrug: Duloxetine Hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00191919
180489180489Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)CompletedHas ResultsAttention Deficit Hyperactivity Disorder|Reading DisorderDrug: Atomoxetine Hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT00191906
180490180490Bone Effects of Teriparatide Following AlendronateCompletedNo Results AvailableOsteoporosisDrug: teriparatidehttps://ClinicalTrials.gov/show/NCT00191893
180491180491Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity DisorderCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: atomoxetinehttps://ClinicalTrials.gov/show/NCT00191880
180492180492Clinical Trial of Teriparatide in JapanCompletedNo Results AvailableOsteoporosisDrug: Teriparatidehttps://ClinicalTrials.gov/show/NCT00191867
180493180493Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st LineCompletedHas ResultsBreast CancerDrug: gemcitabine|Drug: paclitaxel|Drug: carboplatin|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00191854
180494180494Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC ChemotherapyCompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: gemcitabine|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00191841
180495180495A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeCompletedNo Results AvailableWeight GainDrug: olanzapinehttps://ClinicalTrials.gov/show/NCT00191828
180496180496Combination Chemotherapy for Metastatic Breast CancerCompletedHas ResultsBreast CancerDrug: Gemcitabine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00191815
180497180497Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic PatientsCompletedNo Results AvailableOsteoporosisDrug: teriparatidehttps://ClinicalTrials.gov/show/NCT00191802
180498180498Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast CancerCompletedHas ResultsBreast CancerDrug: gemcitabine|Drug: doxorubicin|Drug: cisplatin|Procedure: surgeryhttps://ClinicalTrials.gov/show/NCT00191789
180499180499Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung CancerCompletedNo Results AvailableCarcinoma, Non-Small-Cell-Lung CancerDrug: Gemcitabine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00191763
180500180500A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCompletedNo Results AvailableCarcinoma, Small CellDrug: Pemetrexedhttps://ClinicalTrials.gov/show/NCT00191750
180501180501An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Atomoxetinehttps://ClinicalTrials.gov/show/NCT00191737
180502180502Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory StudyCompletedHas ResultsSubmassive Pulmonary EmbolismDrug: Drotrecogin Alfa (Activated)|Drug: Enoxaparin|Drug: Placebo|Drug: Drotrecogin Alfa (Activated)|Drug: Drotrecogin Alfa (Activated)|Drug: Drotrecogin Alfa (Activated)https://ClinicalTrials.gov/show/NCT00191724
180503180503Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.CompletedNo Results AvailableSuperficial Bladder CancerDrug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00191711
180504180504Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODDCompletedNo Results AvailableAttention Deficit Hyperactivity Disorder|Oppositional Defiant DisorderDrug: atomoxetine hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT00191698
180505180505Duloxetine in the Treatment of Melancholic DepressionCompletedNo Results AvailableDepressive Disorder, MajorDrug: duloxetinehttps://ClinicalTrials.gov/show/NCT00191685
180506180506A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNo Results AvailableBreast NeoplasmsDrug: Gemcitabine|Drug: Paclitaxel|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00191672
180507180507Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Atomoxetine Hydrochloridehttps://ClinicalTrials.gov/show/NCT00191659
180508180508An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyCompletedHas ResultsGenital Neoplasms, Female|Fallopian Tube Neoplasms|Ovarian Neoplasms|Pelvic Neoplasms|Peritoneal NeoplasmsDrug: Gemcitabine|Drug: Paclitaxel|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00191646
180509180509Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional OutcomesCompletedNo Results AvailableAttention-Deficit/Hyperactivity DisorderDrug: Atomoxetinehttps://ClinicalTrials.gov/show/NCT00191633
180510180510Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.CompletedNo Results AvailableNon-Small-Cell Lung CarcinomaDrug: Gemcitabine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00191620

* Görseller ve İçerik tekif hakkına sahip olabilir